Editorial research desk with papers, water and hemp seeds
Independent journal · Issue 01

Cannabis,
without the fog.

We examine cannabinoids, consumer products and policy with evidence in view and uncertainty left intact.

Read the lead story
01 / 05
The StateWide position

A clear view is more useful than a confident claim. We separate laboratory findings from clinical proof, product language from regulation, and old internet lore from current guidance.

Evidence desk

CBD and cancer: what the research can, and cannot, tell us

Laboratory findings make headlines. They do not by themselves show that CBD treats lung cancer or any other cancer in people.

Open the evidence file ↗
THE SHORT READ

Preclinical research can shape the next question. It cannot, by itself, show that CBD treats cancer in people.

What counts as evidence?
Filed this issue

Five pieces.
No miracle claims.

05
Guest dispatch

Read the label, not the promise

A guest note from CBD Collective on the small checks that make a big difference when comparing CBD products.

How we work

Useful scepticism,
clearly applied.

01

Primary first

We prioritise regulators, public health bodies and the underlying research over recycled claims.

02

Dates visible

Guidance changes. Every guide carries a review date and links readers back to the current source.

03

Limits included

We state what evidence cannot establish, not only what appears promising.

Guest desk
From CBD Collective

Read the label,
not the promise.

A guest dispatch on the small checks that make a big difference when comparing products.

Read the dispatch